Regulation of the mesolimbic dopamine circuit by feeding peptides

Neuroscience

Volumn 289, Issue , 2015, Pages 19-42

  Liu, S ^a   Borgland, S L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anorectic; Dopamine; Feeding peptides; Ingestive behavior; Orexigenic; Ventral tegmental area

Indexed keywords

AGOUTI RELATED PEPTIDE; ALPHA INTERMEDIN; AMYLIN; CENTRALLY DERIVED ANOREXIGENIC PEPTIDE; CENTRALLY DERIVED OREXIGENIC PEPTIDE; CHOLECYSTOKININ; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; FEEDING PEPTIDE; GALANIN; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE Y; NEUROTENSIN; OPIATE PEPTIDE; OREXIN; PEPTIDE; PERIPHERALLY DERIVED ANOREXIGENIC PEPTIDE; PERIPHERALLY DERIVED OREXIGENIC PEPTIDE; UNCLASSIFIED DRUG;

CLEARANCE; DOPAMINE CLEARANCE; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; INTRACELLULAR SIGNALING; MESOLIMBIC DOPAMINERGIC SYSTEM; MOLECULAR DYNAMICS; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; VENTRAL TEGMENTUM; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; DOPAMINERGIC NEURONS; FEEDING BEHAVIOR; HUMANS; PEPTIDES; VENTRAL TEGMENTAL AREA;

EID: 84921900482     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.12.046     Document Type: Review

References (328)

1. Abizaid A., Liu Z.-W., Andrews Z.B., Shanabrough M., Borok E., Elsworth J.D., Roth R.H., Sleeman M.W., Picciotto M.R., Tschöp M.H., Gao X.-B., Horvath T.L. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 2006, 116:3229-3239.
2. Alhadeff A.L., Rupprecht L.E., Hayes M.R. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 2012, 153:647-658.
3. Anderberg R.H., Anefors C., Bergquist F., Nissbrandt H., Skibicka K.P. Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior. Physiol Behav 2014.
4. Aponte Y., Atasoy D., Sternson S.M. AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat Neurosci 2011, 14:351-355.
5. Asakawa A., Inui A., Ueno N., Makino S., Fujino M.A., Kasuga M. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology 1999, 116:1287-1292.
6. Atasoy D., Betley J.N., Su H.H., Sternson S.M. Deconstruction of a neural circuit for hunger. Nature 2012, 488:172-177.
7. Badiani A., Leone P., Noel M.B., Stewart J. Ventral tegmental area opioid mechanisms and modulation of ingestive behavior. Brain Res 1995, 670:264-276.
8. Baimel C., Bartlett S.E., Chiou L.-C., Lawrence A.J., Muschamp J.W., Patkar O., Tung L.-W., Borgland S.L. Orexin/hypocretin role in reward: implications for opioid and other addictions. Br J Pharmacol 2014.
9. Balcita-Pedicino J.J., Sesack S.R. Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and gamma-aminobutyric acid neurons. J Comp Neurol 2007, 503:668-684.
10. Balopole D.C., Hansult C.D., Dorph D. Effect of cocaine on food intake in rats. Psychopharmacology 1979, 64:121-122.
11. Banks W.A., Kastin A.J., Huang W., Jaspan J.B., Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996, 17:305-311.
12. Barson J.R., Morganstern I., Leibowitz S.F. Galanin and consummatory behavior: special relationship with dietary fat, alcohol and circulating lipids. EXS 2010, 102:87-111.
13. Bedford J.A., Borne R.F., Wilson M.C. Comparative behavioral profile of cocaine and norcocaine in rats and monkeys. Pharmacol Biochem Behav 1980, 13:69-75.
14. Beeler J.A., Daw N., Frazier C.R.M., Zhuang X. Tonic dopamine modulates exploitation of reward learning. Front Behav Neurosci 2010, 4:170.
15. Blacktop J.M., Seubert C., Baker D.A., Ferda N., Lee G., Graf E.N., Mantsch J.R. Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2. J Neurosci 2011, 31:11396-11403.
16. Blevins J.E., Stanley B.G., Reidelberger R.D. Brain regions where cholecystokinin suppresses feeding in rats. Brain Res 2000, 860:1-10.
17. Bodnar R.J., Lamonte N., Israel Y., Kandov Y., Ackerman T.F., Khaimova E. Reciprocal opioid-opioid interactions between the ventral tegmental area and nucleus accumbens regions in mediating mu agonist-induced feeding in rats. Peptides 2005, 26:621-629.
18. Booth D.A. Amphetamine anorexia by direct action on the adrenergic feeding system of rat hypothalamus. Nature 1968, 217:869-870.
19. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49:589-601.
20. Borgland S.L., Storm E., Bonci A. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. Eur J Neurosci 2008, 28:1545-1556.
21. Borgland S.L., Chang S.-J., Bowers M.S., Thompson J.L., Vittoz N., Floresco S.B., Chou J., Chen B.T., Bonci A. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 2009, 29:11215-11225.
22. Broberger C., Johansen J., Johansson C., Schalling M., Hökfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci U S A 1998, 95:15043-15048.
23. Brodie M.S., Dunwiddie T.V. Cholecystokinin potentiates dopamine inhibition of mesencephalic dopamine neurons in vitro. Brain Res 1987, 425:106-113.
24. Brown C.M., Fletcher P.J., Coscina D.V. Neuropeptide Y-induced operant responding for sucrose is not mediated by dopamine. Peptides 1998, 19:1667-1673.
25. Brown L.M., Clegg D.J., Benoit S.C., Woods S.C. Intraventricular insulin and leptin reduce food intake and body weight in C57BL/6J mice. Physiol Behav 2006, 89:687-691.
26. Bruijnzeel A.W., Corrie L.W., Rogers J.A., Yamada H. Effects of insulin and leptin in the ventral tegmental area and arcuate hypothalamic nucleus on food intake and brain reward function in female rats. Behav Brain Res 2011, 219:254-264.
27. Bruijnzeel A.W., Qi X., Corrie L.W. Anorexic effects of intra-VTA leptin are similar in low-fat and high-fat-fed rats but attenuated in a subgroup of high-fat-fed obese rats. Pharmacol Biochem Behav 2013, 103:573-581.
28. Brüning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Müller-Wieland D., Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289:2122-2125.
29. Cador M., Kelley A.E., Le Moal M., Stinus L. Ventral tegmental area infusion of substance P, neurotensin and enkephalin: differential effects on feeding behavior. Neuroscience 1986, 18:659-669.
30. Cador M., Rivet J.M., Kelley A.E., Le Moal M., Stinus L. Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res 1989, 486:357-363.
31. Campos R.V., Lee Y.C., Drucker D.J. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 1994, 134:2156-2164.
32. Cardot J., Griffond B., Risold P.Y., Blähser S., Fellmann D. Melanin-concentrating hormone-producing neurons in birds. J Comp Neurol 1999, 411:239-256.
33. Carraway R., Leeman S.E. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 1973, 248:6854-6861.
34. Carter M.E., Soden M.E., Zweifel L.S., Palmiter R.D. Genetic identification of a neural circuit that suppresses appetite. Nature 2013, 503:111-114.
35. Carvelli L., Morón J.A., Kahlig K.M., Ferrer J.V., Sen N., Lechleiter J.D., Leeb-Lundberg L.M.F., Merrill G., Lafer E.M., Ballou L.M., Shippenberg T.S., Javitch J.A., Lin R.Z., Galli A. PI 3-kinase regulation of dopamine uptake. J Neurochem 2002, 81:859-869.
36. Cason A.M., Smith R.J., Tahsili-Fahadan P., Moorman D.E., Sartor G.C., Aston-Jones G. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav 2010, 100:419-428.
37. Chance W.T., Balasubramaniam A., Zhang F.S., Wimalawansa S.J., Fischer J.E. Anorexia following the intrahypothalamic administration of amylin. Brain Res 1991, 539:352-354.
38. Chavez M., Kaiyala K., Madden L.J., Schwartz M.W., Woods S.C. Intraventricular insulin and the level of maintained body weight in rats. Behav Neurosci 1995, 109:528-531.
39. Chen N.A., Jupp B., Sztainberg Y., Lebow M., Brown R.M., Kim J.H., Chen A., Lawrence A.J. Knockdown of CRF1 receptors in the ventral tegmental area attenuates cue- and acute food deprivation stress-induced cocaine seeking in mice. J Neurosci 2014, 34:11560-11570.
40. Chiodo L.A., Freeman A.S., Bunney B.S. Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide. Brain Res 1987, 410:205-211.
41. Choi D.L., Davis J.F., Magrisso I.J., Fitzgerald M.E., Lipton J.W., Benoit S.C. Orexin signaling in the paraventricular thalamic nucleus modulates mesolimbic dopamine and hedonic feeding in the rat. Neuroscience 2012, 210:243-248.
42. Chou T.C., Lee C.E., Lu J., Elmquist J.K., Hara J., Willie J.T., Beuckmann C.T., Chemelli R.M., Sakurai T., Yanagisawa M., Saper C.B., Scammell T.E. Orexin (hypocretin) neurons contain dynorphin. J Neurosci 2001, 21:RC168.
43. Clark J.T., Kalra P.S., Crowley W.R., Kalra S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984, 115:427-429.
44. Coker G.T., Studelska D., Harmon S., Burke W., O'Malley K.L. Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Brain Res Mol Brain Res 1990, 8:93-98.
45. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005, 8:571-578.
46. Cone J.J., McCutcheon J.E., Roitman M.F. Ghrelin acts as an interface between physiological state and phasic dopamine signaling. J Neurosci 2014, 34:4905-4913.
47. Couceyro P., Paquet M., Koylu E., Kuhar M.J., Smith Y. Cocaine- and amphetamine-regulated transcript (CART) peptide immunoreactivity in myenteric plexus neurons of the rat ileum and co-localization with choline acetyltransferase. Synapse 1998, 30:1-8.
48. Criscione L., Rigollier P., Batzl-Hartmann C., Rüeger H., Stricker-Krongrad A., Wyss P., Brunner L., Whitebread S., Yamaguchi Y., Gerald C., Heurich R.O., Walker M.W., Chiesi M., Schilling W., Hofbauer K.G., Levens N. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor. J Clin Invest 1998, 102:2136-2145.
49. Cummings S., Elde R., Ells J., Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 1983, 3:1355-1368.
50. Dallvechia-Adams S., Smith Y., Kuhar M.J. CART peptide-immunoreactive projection from the nucleus accumbens targets substantia nigra pars reticulata neurons in the rat. J Comp Neurol 2001, 434:29-39.
51. Dallvechia-Adams S., Kuhar M.J., Smith Y. Cocaine- and amphetamine-regulated transcript peptide projections in the ventral midbrain: colocalization with gamma-aminobutyric acid, melanin-concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons. J Comp Neurol 2002, 448:360-372.
52. Davis J.F., Choi D.L., Schurdak J.D., Fitzgerald M.F., Clegg D.J., Lipton J.W., Figlewicz D.P., Benoit S.C. Leptin regulates energy balance and motivation through action at distinct neural circuits. Biol Psychiatry 2011, 69:668-674.
53. Davis J.F., Choi D.L., Shurdak J.D., Krause E.G., Fitzgerald M.F., Lipton J.W., Sakai R.R., Benoit S.C. Central melanocortins modulate mesocorticolimbic activity and food seeking behavior in the rat. Physiol Behav 2011, 102:491-495.
54. De Barioglio S.R., Lezcano N., Celis M.E. Alpha MSH-induced excessive grooming behavior involves a GABAergic mechanism. Peptides 1991, 12:203-205.
55. De Jonghe B.C., Hajnal A., Covasa M. Increased oral and decreased intestinal sensitivity to sucrose in obese, prediabetic CCK-A receptor-deficient OLETF rats. Am J Physiol Regul Integr Comp Physiol 2005, 288:R292-R300.
56. De Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998, 95:322-327.
57. Deroche V., Marinelli M., Maccari S., Le Moal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J Neurosci 1995, 15:7181-7188.
58. Deutch A.Y., Roth R.H. Calcitonin gene-related peptide in the ventral tegmental area: selective modulation of prefrontal cortical dopamine metabolism. Neurosci Lett 1987, 74:169-174.
59. Devine D.P., Leone P., Pocock D., Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 1993, 266:1236-1246.
60. Di Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 1988, 244:1067-1080.
61. Dickson S.L., Hrabovszky E., Hansson C., Jerlhag E., Alvarez-Crespo M., Skibicka K.P., Molnar C.S., Liposits Z., Engel J.A., Egecioglu E. Blockade of central nicotine acetylcholine receptor signaling attenuate ghrelin-induced food intake in rodents. Neuroscience 2010, 171:1180-1186.
62. Dickson S.L., Shirazi R.H., Hansson C., Bergquist F., Nissbrandt H., Skibicka K.P. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 2012, 32:4812-4820.
63. Domingos A.I., Vaynshteyn J., Voss H.U., Ren X., Gradinaru V., Zang F., Deisseroth K., de Araujo I.E., Friedman J. Leptin regulates the reward value of nutrient. Nat Neurosci 2011, 14:1562-1568.
64. Domingos A.I., Sordillo A., Dietrich M.O., Liu Z.-W., Tellez L.A., Vaynshteyn J., Ferreira J.G., Ekstrand M.I., Horvath T.L., de Araujo I.E., Friedman J.M. Hypothalamic melanin concentrating hormone neurons communicate the nutrient value of sugar. eLife 2013, 2:e01462.
65. Dossat A.M., Lilly N., Kay K., Williams D.L. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J Neurosci 2011, 31:14453-14457.
66. Douglass J., McKinzie A.A., Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 1995, 15:2471-2481.
67. Egecioglu E., Jerlhag E., Salomé N., Skibicka K.P., Haage D., Bohlooly-Y M., Andersson D., Bjursell M., Perrissoud D., Engel J.A., Dickson S.L. Ghrelin increases intake of rewarding food in rodents. Addict Biol 2010, 15:304-311.
68. Egecioglu E., Engel J.A., Jerlhag E. The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice. PLoS One 2013, 8:e69010.
69. Egecioglu E., Steensland P., Fredriksson I., Feltmann K., Engel J.A., Jerlhag E. The glucagon-like peptide 1 analogue exendin-4 attenuates alcohol mediated behaviors in rodents. Psychoneuroendocrinology 2013, 38:1259-1270.
70. Elmquist J.K., Bjørbaek C., Ahima R.S., Flier J.S., Saper C.B. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 1998, 395:535-547.
71. Ericson E., Ahlenius S. Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic neurotransmission. Brain Res 1999, 822:200-209.
72. España R.A., Oleson E.B., Locke J.L., Brookshire B.R., Roberts D.C.S., Jones S.R. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci 2010, 31:336-348.
73. España R.A., Melchior J.R., Roberts D.C.S., Jones S.R. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology 2011, 214:415-426.
74. Evrard A., Changeux J.-P. Abnormal response of dopaminergic neurons to nicotine without perturbation of nicotinic receptors in alphaCGRP knock-out mice. Brain Res 2008, 1228:89-96.
75. Fadel J., Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002, 111:379-387.
76. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385:165-168.
77. Feifel D., Shilling P.D., Kuczenski R., Segal D.S. Altered extracellular dopamine concentration in the brains of cholecystokinin-A receptor deficient rats. Neurosci Lett 2003, 348:147-150.
78. Fibiger H.C., Phillips A.G., Clouston R.A. Regulatory deficits after unilateral electrolytic or 6-OHDA lesions of the substantia nigra. Am J Physiol 1973, 225:1282-1287.
79. Figlewicz D.P., Szot P., Chavez M., Woods S.C., Veith R.C. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res 1994, 644:331-334.
80. Figlewicz D.P., Brot M.D., McCall A.L., Szot P. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res 1996, 736:54-60.
81. Figlewicz D.P., Patterson T.A., Johnson L.B., Zavosh A., Israel P.A., Szot P. Dopamine transporter mRNA is increased in the CNS of Zucker fatty (fa/fa) rats. Brain Res Bull 1998, 46:199-202.
82. Figlewicz D.P., Evans S.B., Murphy J., Hoen M., Baskin D.G. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res 2003, 964:107-115.
83. Figlewicz D.P., Bennett J., Evans S.B., Kaiyala K., Sipols A.J., Benoit S.C. Intraventricular insulin and leptin reverse place preference conditioned with high-fat diet in rats. Behav Neurosci 2004, 118:479-487.
84. Figlewicz D.P., MacDonald Naleid A., Sipols A.J. Modulation of food reward by adiposity signals. Physiol Behav 2007, 91:473-478.
85. Ford C.P., Mark G.P., Williams J.T. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 2006, 26:2788-2797.
86. Frommelt L., Lembke V., Hofmann T., Goebel-Stengel M., Mönnikes H., Wiedenmann B., Klapp B.F., Stengel A., Kobelt P. The CCKB antagonist CI988 reduces food intake in fasted rats via a dopamine mediated pathway. Peptides 2013, 39:111-118.
87. Fulton S., Woodside B., Shizgal P. Modulation of brain reward circuitry by leptin. Science 2000, 287:125-128.
88. Fulton S., Pissios P., Manchon R.P., Stiles L., Frank L., Pothos E.N., Maratos-Flier E., Flier J.S. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006, 51:811-822.
89. Garcia B.G., Wei Y., Moron J.A., Lin R.Z., Javitch J.A., Galli A. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol Pharmacol 2005, 68:102-109.
90. Gibbs J., Young R.C., Smith G.P. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 1973, 84:488-495.
91. Gibbs J., Young R.C., Smith G.P. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 1973, 245:323-325.
92. Giddings S.J., Chirgwin J., Permutt M.A. Evaluation of rat insulin messenger RNA in pancreatic and extrapancreatic tissues. Diabetologia 1985, 28:343-347.
93. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 1984, 4:2877-2890.
94. Graham M., Shutter J.R., Sarmiento U., Sarosi I., Stark K.L. Overexpression of Agrt leads to obesity in transgenic mice. Nat Genet 1997, 17:273-274.
95. Grandt D., Schimiczek M., Beglinger C., Layer P., Goebell H., Eysselein V.E., Reeve J.R. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 1994, 51:151-159.
96. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., Smith R.G., Van der Ploeg L.H., Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 1997, 48:23-29.
97. Hajnal A., Covasa M., Bello N.T. Altered taste sensitivity in obese, prediabetic OLETF rats lacking CCK-1 receptors. Am J Physiol Regul Integr Comp Physiol 2005, 289:R1675-R1686.
98. Hajnal A., Margas W.M., Covasa M. Altered dopamine D2 receptor function and binding in obese OLETF rat. Brain Res Bull 2008, 75:70-76.
99. Hallschmid M., Benedict C., Schultes B., Fehm H.-L., Born J., Kern W. Intranasal insulin reduces body fat in men but not in women. Diabetes 2004, 53:3024-3029.
100. Hamilton M.E., Bozarth M.A. Feeding elicited by dynorphin (1-13) microinjections into the ventral tegmental area in rats. Life Sci 1988, 43:941-946.
101. Hansson C., Shirazi R.H., Näslund J., Vogel H., Neuber C., Holm G., Anckarsäter H., Dickson S.L., Eriksson E., Skibicka K.P. Ghrelin influences novelty seeking behavior in rodents and men. PLoS One 2012, 7:e50409.
102. Hauger R.L., Risbrough V., Brauns O., Dautzenberg F.M. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord: Drug Targets 2006, 5:453-479.
103. Havrankova J., Roth J., Brownstein M.J. Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents. J Clin Invest 1979, 64:636-642.
104. Hawes J.J., Picciotto M.R. Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain. J Comp Neurol 2004, 479:410-423.
105. Hawes J.J., Brunzell D.H., Narasimhaiah R., Langel U., Wynick D., Picciotto M.R. Galanin protects against behavioral and neurochemical correlates of opiate reward. Neuropsychopharmacology 2008, 33:1864-1873.
106. Hawkins M.F. Aphagia in the rat following microinjection of neurotensin into the ventral tegmental area. Life Sci 1986, 38:2383-2388.
107. Hawkins M.F. Central nervous system neurotensin and feeding. Physiol Behav 1986, 36:1-8.
108. Hervieu G.J., Cluderay J.E., Harrison D., Meakin J., Maycox P., Nasir S., Leslie R.A. The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat. Eur J Neurosci 2000, 12:1194-1216.
109. Hill D.R., Shaw T.M., Graham W., Woodruff G.N. Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329. J Neurosci 1990, 10:1070-1081.
110. Hoebel B.G., Hernandez L., Schwartz D.H., Mark G.P., Hunter G.A. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications. Ann N Y Acad Sci 1989, 575:171-191. [discussion 192-193].
111. Hökfelt T., Rehfeld J.F., Skirboll L., Ivemark B., Goldstein M., Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature 1980, 285:476-478.
112. Holmes L.J., Smythe G.A., Storlien L.H. Monoaminergic activity at the level of the hypothalamus and striatum: relationship to anticipated feeding and pancreatic insulin responses. Brain Res 1989, 496:204-210.
113. Hommel J.D., Trinko R., Sears R.M., Georgescu D., Liu Z.-W., Gao X.-B., Thurmon J.J., Marinelli M., DiLeone R.J. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006, 51:801-810.
114. Hommer D.W., Stoner G., Crawley J.N., Paul S.M., Skirboll L.R. Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype. J Neurosci 1986, 6:3039-3043.
115. Hsu R., Taylor J.R., Newton S.S., Alvaro J.D., Haile C., Han G., Hruby V.J., Nestler E.J., Duman R.S. Blockade of melanocortin transmission inhibits cocaine reward. Eur J Neurosci 2005, 21:2233-2242.
116. Hubert G.W., Jones D.C., Moffett M.C., Rogge G., Kuhar M.J. CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. Biochem Pharmacol 2008, 75:57-62.
117. Inagaki S., Kito S., Kubota Y., Girgis S., Hillyard C.J., MacIntyre I. Autoradiographic localization of calcitonin gene-related peptide binding sites in human and rat brains. Brain Res 1986, 374:287-298.
118. Ishihara A., Kanatani A., Okada M., Hidaka M., Tanaka T., Mashiko S., Gomori A., Kanno T., Hata M., Kanesaka M., Tominaga Y., Sato N., Kobayashi M., Murai T., Watanabe K., Ishii Y., Fukuroda T., Fukami T., Ihara M. Blockade of body weight gain and plasma corticosterone levels in Zucker fatty rats using an orally active neuropeptide Y Y1 antagonist. Br J Pharmacol 2002, 136:341-346.
119. Jaworski J.N., Vicentic A., Hunter R.G., Kimmel H.L., Kuhar M.J. CART peptides are modulators of mesolimbic dopamine and psychostimulants. Life Sci 2003, 73:741-747.
120. Jaworski J.N., Kimmel H.L., Mitrano D.A., Tallarida R.J., Kuhar M.J. Intra-VTA CART 55-102 reduces the locomotor effect of systemic cocaine in rats: an isobolographic analysis. Neuropeptides 2007, 41:65-72.
121. Jaworski J.N., Hansen S.T., Kuhar M.J., Mark G.P. Injection of CART (cocaine- and amphetamine-regulated transcript) peptide into the nucleus accumbens reduces cocaine self-administration in rats. Behav Brain Res 2008, 191:266-271.
122. Jenck F., Quirion R., Wise R.A. Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding. Brain Res 1987, 423:39-44.
123. Jerlhag E. Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict Biol 2008, 13:358-363.
124. Jerlhag E., Egecioglu E., Dickson S.L., Andersson M., Svensson L., Engel J.A. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol 2006, 11:45-54.
125. Jerlhag E., Egecioglu E., Dickson S.L., Douhan A., Svensson L., Engel J.A. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol 2007, 12:6-16.
126. Jerlhag E., Egecioglu E., Dickson S.L., Svensson L., Engel J.A. Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens. Eur Neuropsychopharmacol 2008, 18:508-518.
127. Jerlhag E., Egecioglu E., Landgren S., Salomé N., Heilig M., Moechars D., Datta R., Perrissoud D., Dickson S.L., Engel J.A. Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci U S A 2009, 106:11318-11323.
128. Jerlhag E., Egecioglu E., Dickson S.L., Engel J.A. Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system. Addict Biol 2011, 16:82-91.
129. Jerlhag E., Janson A.C., Waters S., Engel J.A. Concomitant release of ventral tegmental acetylcholine and accumbal dopamine by ghrelin in rats. PLoS One 2012, 7:e49557.
130. Jewett D.C., Cleary J., Levine A.S., Schaal D.W., Thompson T. Effects of neuropeptide Y on food-reinforced behavior in satiated rats. Pharmacol Biochem Behav 1992, 42:207-212.
131. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992, 12:483-488.
132. Johnson S.W., Seutin V., North R.A. Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump. Science 1992, 258:665-667.
133. Jones M.W., Kilpatrick I.C., Phillipson O.T. Regulation of dopamine function in the nucleus accumbens of the rat by the thalamic paraventricular nucleus and adjacent midline nuclei. Exp Brain Res 1989, 76:572-580.
134. Josselyn S.A., Beninger R.J. Neuropeptide Y: intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol. Pharmacol Biochem Behav 1993, 46:543-552.
135. Kahn S.E., D'Alessio D.A., Schwartz M.W., Fujimoto W.Y., Ensinck J.W., Taborsky G.J., Porte D. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 1990, 39:634-638.
136. Kalivas P.W., Duffy P. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J Neurosci 1990, 10:2940-2949.
137. Kalivas P.W., Miller J.S. Neurotensin neurons in the ventral tegmental area project to the medial nucleus accumbens. Brain Res 1984, 300:157-160.
138. Karatayev O., Baylan J., Leibowitz S.F. Increased intake of ethanol and dietary fat in galanin overexpressing mice. Alcohol 2009, 43:571-580.
139. Kaur S., Ryabinin A.E. Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. Alcohol Clin Exp Res 2010, 34:1525-1534.
140. Kawahara Y., Kawahara H., Kaneko F., Yamada M., Nishi Y., Tanaka E., Nishi A. Peripherally administered ghrelin induces bimodal effects on the mesolimbic dopamine system depending on food-consumptive states. Neuroscience 2009, 161:855-864.
141. Kawahara Y., Kaneko F., Yamada M., Kishikawa Y., Kawahara H., Nishi A. Food reward-sensitive interaction of ghrelin and opioid receptor pathways in mesolimbic dopamine system. Neuropharmacology 2013, 67:395-402.
142. Keire D.A., Mannon P., Kobayashi M., Walsh J.H., Solomon T.E., Reeve J.R. Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am J Physiol Gastrointest Liver Physiol 2000, 279:G126-G131.
143. Kelley A.E., Delfs J.M. Dopamine and conditioned reinforcement. II. Contrasting effects of amphetamine microinjection into the nucleus accumbens with peptide microinjection into the ventral tegmental area. Psychopharmacology 1991, 103:197-203.
144. Kelley A.E., Cador M., Stinus L., Le Moal M. Neurotensin, substance P, neurokinin-alpha, and enkephalin: injection into ventral tegmental area in the rat produces differential effects on operant responding. Psychopharmacology 1989, 97:243-252.
145. Kempadoo K.A., Tourino C., Cho S.L., Magnani F., Leinninger G.-M., Stuber G.D., Zhang F., Myers M.G., Deisseroth K., de Lecea L., Bonci A. Hypothalamic neurotensin projections promote reward by enhancing glutamate transmission in the VTA. J Neurosci 2013, 33:7618-7626.
146. Kim S., Yoon H.S., Kim J.-H. CART peptide 55-102 microinjected into the nucleus accumbens inhibits the expression of behavioral sensitization by amphetamine. Regul Pept 2007, 144:6-9.
147. Kimmel H.L., Gong W., Vechia S.D., Hunter R.G., Kuhar M.J. Intra-ventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference. J Pharmacol Exp Ther 2000, 294:784-792.
148. Kimmel H.L., Thim L., Kuhar M.J. Activity of various CART peptides in changing locomotor activity in the rat. Neuropeptides 2002, 36:9-12.
149. King S.J., Isaacs A.M., O'Farrell E., Abizaid A. Motivation to obtain preferred foods is enhanced by ghrelin in the ventral tegmental area. Horm Behav 2011, 60:572-580.
150. Kishi T., Aschkenasi C.J., Lee C.E., Mountjoy K.G., Saper C.B., Elmquist J.K. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J Comp Neurol 2003, 457:213-235.
151. Kishi T., Aschkenasi C.J., Choi B.J., Lopez M.E., Lee C.E., Liu H., Hollenberg A.N., Friedman J.M., Elmquist J.K. Neuropeptide Y Y1 receptor mRNA in rodent brain: distribution and colocalization with melanocortin-4 receptor. J Comp Neurol 2005, 482:217-243.
152. Klusa V., Svirskis S., Opmane B., Muceniece R., Skujins A., Mutulis F., Wikberg J.E., Schiöth H.B. Evaluation of behavioural effects of neural melanocortin receptor antagonists injected ICV and in VTA in rats. Neuropeptides 1998, 32:573-580.
153. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
154. Kong D., Vong L., Parton L.E., Ye C., Tong Q., Hu X., Choi B., Brüning J.C., Lowell B.B. Glucose stimulation of hypothalamic MCH neurons involves K(ATP) channels, is modulated by UCP2, and regulates peripheral glucose homeostasis. Cell Metab 2010, 12:545-552.
155. Könner A.C., Hess S., Tovar S., Mesaros A., Sánchez-Lasheras C., Evers N., Verhagen L.A.W., Brönneke H.S., Kleinridders A., Hampel B., Kloppenburg P., Brüning J.C. Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. Cell Metab 2011, 13:720-728.
156. Kordower J.H., Le H.K., Mufson E.J. Galanin immunoreactivity in the primate central nervous system. J Comp Neurol 1992, 319:479-500.
157. Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., Brown R.E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 2003, 23:7-11.
158. Korotkova T.M., Brown R.E., Sergeeva O.A., Ponomarenko A.A., Haas H.L. Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur J Neurosci 2006, 23:2677-2685.
159. Kortleven C., Bruneau L.C., Trudeau L.-E. Neurotensin inhibits glutamate-mediated synaptic inputs onto ventral tegmental area dopamine neurons through the release of the endocannabinoid 2-AG. Neuropharmacology 2012, 63:983-991.
160. Krahn D.D., Gosnell B.A., Levine A.S., Morley J.E. Effects of calcitonin gene-related peptide on food intake. Peptides 1984, 5:861-864.
161. Krause M., German P.W., Taha S.A., Fields H.L. A pause in nucleus accumbens neuron firing is required to initiate and maintain feeding. J Neurosci 2010, 30:4746-4756.
162. Krügel U., Schraft T., Kittner H., Kiess W., Illes P. Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur J Pharmacol 2003, 482:185-187.
163. Kyrkouli S.E., Stanley B.G., Leibowitz S.F. Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide. Eur J Pharmacol 1986, 122:159-160.
164. Kyrkouli S.E., Strubbe J.H., Scheurink A.J.W. Galanin in the PVN increases nutrient intake and changes peripheral hormone levels in the rat. Physiol Behav 2006, 89:103-109.
165. Labouèbe G., Liu S., Dias C., Zou H., Wong J.C.Y., Karunakaran S., Clee S.M., Phillips A.G., Boutrel B., Borgland S.L. Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat Neurosci 2013, 16:300-308.
166. Laitinen K., Crawley J.N., Mefford I.N., De Witte P. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens. Brain Res 1990, 523:342-346.
167. Lambert P.D., Couceyro P.R., McGirr K.M., Dall Vechia S.E., Smith Y., Kuhar M.J. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 1998, 29:293-298.
168. Lammel S., Hetzel A., Häckel O., Jones I., Liss B., Roeper J. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 2008, 57:760-773.
169. Lammel S., Ion D.I., Roeper J., Malenka R.C. Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 2011, 70:855-862.
170. Lamont E.W., Patterson Z., Rodrigues T., Vallejos O., Blum I.D., Abizaid A. Ghrelin-deficient mice have fewer orexin cells and reduced cFOS expression in the mesolimbic dopamine pathway under a restricted feeding paradigm. Neuroscience 2012, 218:12-19.
171. Lamonte N., Echo J.A., Ackerman T.F., Christian G., Bodnar R.J. Analysis of opioid receptor subtype antagonist effects upon mu opioid agonist-induced feeding elicited from the ventral tegmental area of rats. Brain Res 2002, 929:96-100.
172. Landgren S., Engel J.A., Hyytiä P., Zetterberg H., Blennow K., Jerlhag E. Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference. Behav Brain Res 2011, 221:182-188.
173. Larsen P.J., Tang-Christensen M., Jessop D.S. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 1997, 138:4445-4455.
174. Leibowitz S.F., Avena N.M., Chang G.-Q., Karatayev O., Chau D.T., Hoebel B.G. Ethanol intake increases galanin mRNA in the hypothalamus and withdrawal decreases it. Physiol Behav 2003, 79:103-111.
175. Leinninger G.M., Jo Y.-H., Leshan R.L., Louis G.W., Yang H., Barrera J.G., Wilson H., Opland D.M., Faouzi M.A., Gong Y., Jones J.C., Rhodes C.J., Chua S., Diano S., Horvath T.L., Seeley R.J., Becker J.B., Münzberg H., Myers M.G. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab 2009, 10:89-98.
176. Leinninger G.M., Opland D.M., Jo Y.-H., Faouzi M., Christensen L., Cappellucci L.A., Rhodes C.J., Gnegy M.E., Becker J.B., Pothos E.N., Seasholtz A.F., Thompson R.C., Myers M.G. Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance. Cell Metab 2011, 14:313-323.
177. Lemos J.C., Wanat M.J., Smith J.S., Reyes B.A.S., Hollon N.G., Van Bockstaele E.J., Chavkin C., Phillips P.E.M. Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature 2012, 490:402-406.
178. Leshan R.L., Opland D.M., Louis G.W., Leinninger G.M., Patterson C.M., Rhodes C.J., Münzberg H., Myers M.G. Ventral tegmental area leptin receptor neurons specifically project to and regulate cocaine- and amphetamine-regulated transcript neurons of the extended central amygdala. J Neurosci 2010, 30:5713-5723.
179. Levine A.S., Morley J.E. Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 1984, 5:1025-1029.
180. Li Y., South T., Han M., Chen J., Wang R., Huang X.-F. High-fat diet decreases tyrosine hydroxylase mRNA expression irrespective of obesity susceptibility in mice. Brain Res 2009, 1268:181-189.
181. Lin Y., Hall R.A., Kuhar M.J. CART peptide stimulation of G protein-mediated signaling in differentiated PC12 cells: identification of PACAP 6-38 as a CART receptor antagonist. Neuropeptides 2011, 45:351-358.
182. Lindblom J., Opmane B., Mutulis F., Mutule I., Petrovska R., Klusa V., Bergström L., Wikberg J.E. The MC4 receptor mediates alpha-MSH induced release of nucleus accumbens dopamine. NeuroReport 2001, 12:2155-2158.
183. Lindblom J., Kask A., Hägg E., Härmark L., Bergström L., Wikberg J. Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain. Pharmacol Res 2002, 45:119-124.
184. Liu H., Kishi T., Roseberry A.G., Cai X., Lee C.E., Montez J.M., Friedman J.M., Elmquist J.K. Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 2003, 23:7143-7154.
185. Liu J., Perez S.M., Zhang W., Lodge D.J., Lu X.-Y. Selective deletion of the leptin receptor in dopamine neurons produces anxiogenic-like behavior and increases dopaminergic activity in amygdala. Mol Psychiatry 2011, 16:1024-1038.
186. Liu S., Labouèbe G., Karunakaran S., Clee S.M., Borgland S.L. Effect of insulin on excitatory synaptic transmission onto dopamine neurons of the ventral tegmental area in a mouse model of hyperinsulinemia. Nutr Diab 2013, 3:e97.
187. Lu D., Willard D., Patel I.R., Kadwell S., Overton L., Kost T., Luther M., Chen W., Woychik R.P., Wilkison W.O. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994, 371:799-802.
188. Lu X.Y., Bagnol D., Burke S., Akil H., Watson S.J. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav 2000, 37:335-344.
189. Ludwig D.S., Tritos N.A., Mastaitis J.W., Kulkarni R., Kokkotou E., Elmquist J., Lowell B., Flier J.S., Maratos-Flier E. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 2001, 107:379-386.
190. Lutz T.A., Del Prete E., Scharrer E. Reduction of food intake in rats by intraperitoneal injection of low doses of amylin. Physiol Behav 1994, 55:891-895.
191. Lutz T.A., Senn M., Althaus J., Del Prete E., Ehrensperger F., Scharrer E. Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats. Peptides 1998, 19:309-317.
192. Lutz T.A., Mollet A., Rushing P.A., Riediger T., Scharrer E. The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats. Int J Obes Relat Metab Disord 2001, 25:1005-1011.
193. Ma W., Chabot J.-G., Powell K.J., Jhamandas K., Dickerson I.M., Quirion R. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience 2003, 120:677-694.
194. MacDonald A.F., Billington C.J., Levine A.S. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. Am J Physiol Regul Integr Comp Physiol 2003, 285:R999-R1004.
195. MacDonald A.F., Billington C.J., Levine A.S. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens. Brain Res 2004, 1018:78-85.
196. Marco A., Schroeder M., Weller A. Feeding and reward: ontogenetic changes in an animal model of obesity. Neuropharmacology 2012, 62:2447-2454.
197. Margolis E.B., Lock H., Chefer V.I., Shippenberg T.S., Hjelmstad G.O., Fields H.L. Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A 2006, 103:2938-2942.
198. Marinelli M., Le Moal M., Piazza P.V. Acute pharmacological blockade of corticosterone secretion reverses food restriction-induced sensitization of the locomotor response to cocaine. Brain Res 1996, 724:251-255.
199. Mark G.P., Shabani S., Dobbs L.K., Hansen S.T. Cholinergic modulation of mesolimbic dopamine function and reward. Physiol Behav 2011, 104:76-81.
200. Martínez-García F., Novejarque A., Landete J.M., Moncho-Bogani J., Lanuza E. Distribution of calcitonin gene-related peptide-like immunoreactivity in the brain of the lizard Podarcis hispanica. J Comp Neurol 2002, 447:99-113.
201. Masuo Y., Giscard-Dartevelle S., Bouizar Z., Rostène W. Effects of cerebral lesions on binding sites for calcitonin and calcitonin gene-related peptide in the rat nucleus accumbens and ventral tegmental area. J Chem Neuroanat 1991, 4:249-257.
202. Matheny M., Shapiro A., Tümer N., Scarpace P.J. Region-specific diet-induced and leptin-induced cellular leptin resistance includes the ventral tegmental area in rats. Neuropharmacology 2011, 60:480-487.
203. Matsui A., Williams J.T. Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons. J Neurosci 2011, 31:17729-17735.
204. McGowan M.K., Andrews K.M., Grossman S.P. Chronic intrahypothalamic infusions of insulin or insulin antibodies alter body weight and food intake in the rat. Physiol Behav 1992, 51:753-766.
205. Mebel D.M., Wong J.C.Y., Dong Y.J., Borgland S.L. Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake. Eur J Neurosci 2012, 36:2336-2346.
206. Meeran K., O'Shea D., Edwards C.M., Turton M.D., Heath M.M., Gunn I., Abusnana S., Rossi M., Small C.J., Goldstone A.P., Taylor G.M., Sunter D., Steere J., Choi S.J., Ghatei M.A., Bloom S.R. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology 1999, 140:244-250.
207. Merchenthaler I., Lane M., Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 1999, 403:261-280.
208. Mietlicki-Baase E.G., Ortinski P.I., Rupprecht L.E., Olivos D.R., Alhadeff A.L., Pierce R.C., Hayes M.R. The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors. Am J Physiol Endocrinol Metab 2013, 305:E1367-E1374.
209. Mietlicki-Baase E.G., Rupprecht L.E., Olivos D.R., Zimmer D.J., Alter M.D., Pierce R.C., Schmidt H.D., Hayes M.R. Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake. Neuropsychopharmacology 2013, 38:1685-1697.
210. Mietlicki-Baase E.G., Ortinski P.I., Reiner D.J., Sinon C.G., McCutcheon J.E., Pierce R.C., Roitman M.F., Hayes M.R. Glucagon-like peptide-1 receptor activation in the nucleus accumbens core suppresses feeding by increasing glutamatergic AMPA/kainate signaling. J Neurosci 2014, 34:6985-6992.
211. Mietlicki-Baase E.G., Reiner D.J., Cone J.J., Olivos D.R., McGrath L.E., Zimmer D.J., Roitman M.F., Hayes M.R. Amylin Modulates the Mesolimbic Dopamine System to Control Energy Balance. Neuropsychopharmacology 2014.
212. Morley J.E., Flood J.F. Amylin decreases food intake in mice. Peptides 1991, 12:865-869.
213. Morton G.J., Blevins J.E., Kim F., Matsen M., Figlewicz D.P. The action of leptin in the ventral tegmental area to decrease food intake is dependent on Jak-2 signaling. Am J Physiol Endocrinol Metab 2009, 297:E202-E210.
214. Mucha R.F., Iversen S.D. Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat. Brain Res 1986, 397:214-224.
215. Muhlhausler B.S., Ong Z.Y. The fetal origins of obesity: early origins of altered food intake. Endocr Metab Immune Disord Drug Targets 2011, 11:189-197.
216. Murase S., Grenhoff J., Chouvet G., Gonon F.G., Svensson T.H. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett 1993, 157:53-56.
217. Muschamp J.W., Dominguez J.M., Sato S.M., Shen R.-Y., Hull E.M. A role for hypocretin (orexin) in male sexual behavior. J Neurosci 2007, 27:2837-2845.
218. Muschamp J.W., Hollander J.A., Thompson J.L., Voren G., Hassinger L.C., Onvani S., Kamenecka T.M., Borgland S.L., Kenny P.J., Carlezon W.A. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proc Natl Acad Sci U S A 2014, 111:E1648-E1655.
219. Naleid A.M., Grace M.K., Cummings D.E., Levine A.S. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 2005, 26:2274-2279.
220. Narasimhaiah R., Kamens H.M., Picciotto M.R. Effects of galanin on cocaine-mediated conditioned place preference and ERK signaling in mice. Psychopharmacology 2009, 204:95-102.
221. Noel M.B., Wise R.A. Ventral tegmental injections of a selective mu or delta opioid enhance feeding in food-deprived rats. Brain Res 1995, 673:304-312.
222. Obici S., Feng Z., Karkanias G., Baskin D.G., Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 2002, 5:566-572.
223. O'Donohue T.L., Dorsa D.M. The opiomelanotropinergic neuronal and endocrine systems. Peptides 1982, 3:353-395.
224. Ollmann M.M., Wilson B.D., Yang Y.K., Kerns J.A., Chen Y., Gantz I., Barsh G.S. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997, 278:135-138.
225. Olson V.G., Nestler E.J. Topographical organization of GABAergic neurons within the ventral tegmental area of the rat. Synapse 2007, 61:87-95.
226. Opland D., Sutton A., Woodworth H., Brown J., Bugescu R., Garcia A., Christensen L., Rhodes C., Myers M., Leinninger G. Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity. Mol Metab 2013, 2:423-434.
227. Palacios J.M., Kuhar M.J. Neurotensin receptors are located on dopamine-containing neurones in rat midbrain. Nature 1981, 294:587-589.
228. Palmiter R.D. Is dopamine a physiologically relevant mediator of feeding behavior?. Trends Neurosci 2007, 30:375-381.
229. Palotai M., Bagosi Z., Jászberényi M., Csabafi K., Dochnal R., Manczinger M., Telegdy G., Szabó G. Ghrelin and nicotine stimulate equally the dopamine release in the rat amygdala. Neurochem Res 2013, 38:1989-1995.
230. Pandit R., Luijendijk M.C.M., Vanderschuren L.J.M.J., la Fleur S.E., Adan R.A.H. Limbic substrates of the effects of neuropeptide Y on intake of and motivation for palatable food. Obesity (Silver Spring) 2014, 22:1216-1219.
231. Pardini A.W., Nguyen H.T., Figlewicz D.P., Baskin D.G., Williams D.L., Kim F., Schwartz M.W. Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis. Brain Res 2006, 1112:169-178.
232. Parsons M.P., Li S., Kirouac G.J. Functional and anatomical connection between the paraventricular nucleus of the thalamus and dopamine fibers of the nucleus accumbens. J Comp Neurol 2007, 500:1050-1063.
233. Patterson T.A., Brot M.D., Zavosh A., Schenk J.O., Szot P., Figlewicz D.P. Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 1998, 68:11-20.
234. Perello M., Sakata I., Birnbaum S., Chuang J.-C., Osborne-Lawrence S., Rovinsky S.A., Woloszyn J., Yanagisawa M., Lutter M., Zigman J.M. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol Psychiatry 2010, 67:880-886.
235. Perry M.L., Leinninger G.M., Chen R., Luderman K.D., Yang H., Gnegy M.E., Myers M.G., Kennedy R.T. Leptin promotes dopamine transporter and tyrosine hydroxylase activity in the nucleus accumbens of Sprague-Dawley rats. J Neurochem 2010, 114:666-674.
236. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
237. Pickel V.M., Beck-Sickinger A.G., Chan J., Weiland H.A. Y1 receptors in the nucleus accumbens: ultrastructural localization and association with neuropeptide Y. J Neurosci Res 1998, 52:54-68.
238. Pinnock R.D. Neurotensin depolarizes substantia nigra dopamine neurones. Brain Res 1985, 338:151-154.
239. Polidori C., Geary N., Massi M. Effect of the melanocortin receptor stimulation or inhibition on ethanol intake in alcohol-preferring rats. Peptides 2006, 27:144-149.
240. Powley T.L. The ventromedial hypothalamic syndrome, satiety, and a cephalic phase hypothesis. Psychol Rev 1977, 84:89-126.
241. Qu D., Ludwig D.S., Gammeltoft S., Piper M., Pelleymounter M.A., Cullen M.J., Mathes W.F., Przypek R., Kanarek R., Maratos-Flier E. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996, 380:243-247.
242. Quarta D., Di Francesco C., Melotto S., Mangiarini L., Heidbreder C., Hedou G. Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens. Neurochem Int 2009, 54:89-94.
243. Quarta D., Leslie C.P., Carletti R., Valerio E., Caberlotto L. Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas. Neuropharmacology 2011, 60:328-335.
244. Rada P., Avena N.M., Leibowitz S.F., Hoebel B.G. Ethanol intake is increased by injection of galanin in the paraventricular nucleus and reduced by a galanin antagonist. Alcohol 2004, 33:91-97.
245. Reum T., Schäfer U., Marsden C.A., Fink H., Morgenstern R. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry. Neuropeptides 1997, 31:82-88.
246. Rinaman L. Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res 2010, 1350:18-34.
247. Roseberry A.G. Altered feeding and body weight following melanocortin administration to the ventral tegmental area in adult rats. Psychopharmacology 2013, 226:25-34.
248. Roseberry A.G., Painter T., Mark G.P., Williams J.T. Decreased vesicular somatodendritic dopamine stores in leptin-deficient mice. J Neurosci 2007, 27:7021-7027.
249. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., Entwistle M.L., Simerly R.B., Cone R.D. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci U S A 1993, 90:8856-8860.
250. Rossi M., Choi S.J., O'Shea D., Miyoshi T., Ghatei M.A., Bloom S.R. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 1997, 138:351-355.
251. Rushing P.A., Hagan M.M., Seeley R.J., Lutz T.A., D'Alessio D.A., Air E.L., Woods S.C. Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 2001, 142:5035.
252. Saito Y., Cheng M., Leslie F.M., Civelli O. Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J Comp Neurol 2001, 435:26-40.
253. Sakurai T., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
254. Salamone J.D., Correa M. The mysterious motivational functions of mesolimbic dopamine. Neuron 2012, 76:470-485.
255. Salmon A.M., Damaj M.I., Marubio L.M., Epping-Jordan M.P., Merlo-Pich E., Changeux J.P. Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice. Nat Neurosci 2001, 4:357-358.
256. Salmon A.-M., Evrard A., Damaj I., Changeux J.-P. Reduction of withdrawal signs after chronic nicotine exposure of alpha-calcitonin gene-related peptide knock-out mice. Neurosci Lett 2004, 360:73-76.
257. Sanchez M.S., Celis M.E., Schiöth H.B. Evidence that alpha-MSH induced grooming is not primarily mediated by any of the cloned melanocortin receptors. Neuropeptides 2000, 34:77-82.
258. Sánchez M.S., Barontini M., Armando I., Celis M.E. Correlation of increased grooming behavior and motor activity with alterations in nigrostriatal and mesolimbic catecholamines after alpha-melanotropin and neuropeptide glutamine-isoleucine injection in the rat ventral tegmental area. Cell Mol Neurobiol 2001, 21:523-533.
259. Scarpace P.J., Matheny M., Kirichenko N., Gao Y.X., Tümer N., Zhang Y. Leptin overexpression in VTA trans-activates the hypothalamus whereas prolonged leptin action in either region cross-desensitizes. Neuropharmacology 2013, 65:90-100.
260. Schultz W., Dayan P., Montague P.R. A neural substrate of prediction and reward. Science 1997, 275:1593-1599.
261. Sedki F., Abbas Z., Angelis S., Martin J., D'Cunha T., Shalev U. Is it stress? The role of stress related systems in chronic food restriction-induced augmentation of heroin seeking in the rat. Front Neurosci 2013, 7:98.
262. Seroogy K., Ceccatelli S., Schalling M., Hökfelt T., Frey P., Walsh J., Dockray G., Brown J., Buchan A., Goldstein M. A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin. Brain Res 1988, 455:88-98.
263. Shimada M., Tritos N.A., Lowell B.B., Flier J.S., Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998, 396:670-674.
264. Shirazi R.H., Dickson S.L., Skibicka K.P. Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward. PLoS One 2013, 8:e61965.
265. Shoji Y., Delfs J., Williams J.T. Presynaptic inhibition of GABA(B)-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal. J Neurosci 1999, 19:2347-2355.
266. Simon J.R., Bare D.J., Ghetti B., Richter J.A. A possible role for tyrosine kinases in the regulation of the neuronal dopamine transporter in mouse striatum. Neurosci Lett 1997, 224:201-205.
267. Skibicka K.P., Hansson C., Alvarez-Crespo M., Friberg P.A., Dickson S.L. Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience 2011, 180:129-137.
268. Skibicka K.P., Hansson C., Egecioglu E., Dickson S.L. Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression. Addict Biol 2012, 17:95-107.
269. Skibicka K.P., Shirazi R.H., Hansson C., Dickson S.L. Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward. Endocrinology 2012, 153:1194-1205.
270. Skibicka K.P., Shirazi R.H., Rabasa-Papio C., Alvarez-Crespo M., Neuber C., Vogel H., Dickson S.L. Divergent circuitry underlying food reward and intake effects of ghrelin: dopaminergic VTA-accumbens projection mediates ghrelin's effect on food reward but not food intake. Neuropharmacology 2013, 73:274-283.
271. Skofitsch G., Jacobowitz D.M. Quantitative distribution of calcitonin gene-related peptide in the rat central nervous system. Peptides 1985, 6:1069-1073.
272. Skofitsch G., Jacobowitz D.M., Zamir N. Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain. Brain Res Bull 1985, 15:635-649.
273. Skofitsch G., Sills M.A., Jacobowitz D.M. Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system. Peptides 1986, 7:1029-1042.
274. Smith D.G., Tzavara E.T., Shaw J., Luecke S., Wade M., Davis R., Salhoff C., Nomikos G.G., Gehlert D.R. Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci 2005, 25:914-922.
275. Sotty F., Soulière F., Brun P., Chouvet G., Steinberg R., Soubrié P., Renaud B., Suaud-Chagny M.F. Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: a combined in vivo electrochemical and electrophysiological study. Neuroscience 1998, 85:1173-1182.
276. Spanagel R., Herz A., Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 1990, 55:1734-1740.
277. Stengel A., Taché Y. CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress. Front Neurosci 2014, 8:52.
278. St-Gelais F., Legault M., Bourque M.-J., Rompré P.-P., Trudeau L.-E. Role of calcium in neurotensin-evoked enhancement in firing in mesencephalic dopamine neurons. J Neurosci 2004, 24:2566-2574.
279. Suaud-Chagny M.F., Chergui K., Chouvet G., Gonon F. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience 1992, 49:63-72.
280. Suchankova P., Steensland P., Fredriksson I., Engel J.A., Jerlhag E. Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption. PLoS One 2013, 8:e71284.
281. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983, 36:165-186.
282. Sweet D.C., Levine A.S., Billington C.J., Kotz C.M. Feeding response to central orexins. Brain Res 1999, 821:535-538.
283. Tan C.P., et al. Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Genomics 2002, 79:785-792.
284. Tanda G., Di Chiara G. A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. Eur J Neurosci 1998, 10:1179-1187.
285. Tang-Christensen M., Larsen P.J., Göke R., Fink-Jensen A., Jessop D.S., Møller M., Sheikh S.P. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol 1996, 271:R848-R856.
286. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A 1982, 79:5485-5489.
287. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982, 296:659-660.
288. Thompson J.L., Borgland S.L. Presynaptic leptin action suppresses excitatory synaptic transmission onto ventral tegmental area dopamine neurons. Biol Psychiatry 2013, 73:860-868.
289. Tillet Y., Batailler M., Fellmann D. Distribution of melanin-concentrating hormone (MCH)-like immunoreactivity in neurons of the diencephalon of sheep. J Chem Neuroanat 1996, 12:135-145.
290. Torre E., Celis M.E. Alpha-MSH injected into the substantia nigra or intraventricularly alters behavior and the striatal dopaminergic activity. Neurochem Int 1986, 9:85-89.
291. Torre E., Celis M.E. Cholinergic mediation in the ventral tegmental area of alpha-melanotropin induced excessive grooming: changes of the dopamine activity in the nucleus accumbens and caudate putamen. Life Sci 1988, 42:1651-1657.
292. Torre E., Celis M.E. Alpha-Melanotropin induced excessive grooming involves brain acetylcholine possible interaction in the ventral tegmental area. Acta Physiol Pharmacol Latinoam 1989, 39:49-56.
293. Toshinai K., Date Y., Murakami N., Shimada M., Mondal M.S., Shimbara T., Guan J.-L., Wang Q.-P., Funahashi H., Sakurai T., Shioda S., Matsukura S., Kangawa K., Nakazato M. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 2003, 144:1506-1512.
294. Trinko R., Gan G., Gao X.-B., Sears R.M., Guarnieri D.J., DiLeone R.J. Erk1/2 mediates leptin receptor signaling in the ventral tegmental area. PLoS One 2011, 6:e27180.
295. Tschöp M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407:908-913.
296. Tsuda K., Tsuda S., Nishio I., Masuyama Y., Goldstein M. Effects of galanin on dopamine release in the central nervous system of normotensive and spontaneously hypertensive rats. Am J Hypertens 1998, 11:1475-1479.
297. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M., Meeran K., Choi S.J., Taylor G.M., Heath M.M., Lambert P.D., Wilding J.P., Smith D.M., Ghatei M.A., Herbert J., Bloom S.R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996, 379:69-72.
298. Uhl G.R. Distribution of neurotensin and its receptor in the central nervous system. Ann N Y Acad Sci 1982, 400:132-149.
299. Ungerstedt U. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 1971, 367:95-122.
300. Ungless M.A., Singh V., Crowder T.L., Yaka R., Ron D., Bonci A. Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons. Neuron 2003, 39:401-407.
301. Van den Heuvel J.K., Furman K., Gumbs M.C.R., Eggels L., Opland D.M., Land B.B., Kolk S.M., Narayanan N., Fliers E., Kalsbeek A., DiLeone R.J., la Fleur S.E. Neuropeptide Y activity in the nucleus accumbens modulates feeding behavior and neuronal activity. Biol Psychiatry 2014.
302. Verhagen L.A.W., Luijendijk M.C.M., Adan R.A.H. Leptin reduces hyperactivity in an animal model for anorexia nervosa via the ventral tegmental area. Eur Neuropsychopharmacol 2011, 21:274-281.
303. Vittoz N.M., Berridge C.W. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 2006, 31:384-395.
304. Wanat M.J., Bonci A., Phillips P.E. CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors. Nat Neurosci 2013, 16:383-385.
305. Wanat M.J., Hopf F.W., Stuber G.D., Phillips P.E.M., Bonci A. Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J Physiol 2008, 586:2157-2170.
306. Wang H.Y., Wild K.D., Shank R.P., Lee D.H. Galanin inhibits acetylcholine release from rat cerebral cortex via a pertussis toxin-sensitive G(i)protein. Neuropeptides 1999, 33:197-205.
307. Weinberg Z.Y., Nicholson M.L., Currie P.J. 6-Hydroxydopamine lesions of the ventral tegmental area suppress ghrelin's ability to elicit food-reinforced behavior. Neurosci Lett 2011, 499:70-73.
308. Will M.J., Franzblau E.B., Kelley A.E. Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci 2003, 23:2882-2888.
309. Wilson C., Nomikos G.G., Collu M., Fibiger H.C. Dopaminergic correlates of motivated behavior: importance of drive. J Neurosci 1995, 15:5169-5178.
310. Wolak M.L., DeJoseph M.R., Cator A.D., Mokashi A.S., Brownfield M.S., Urban J.H. Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J Comp Neurol 2003, 464:285-311.
311. Woods S.C., D'Alessio D.A. Central control of body weight and appetite. J Clin Endocrinol Metab 2008, 93:S37-S50.
312. Woods S.C., Lotter E.C., McKay L.D., Porte D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 1979, 282:503-505.
313. Woods S.C., Seeley R.J., Baskin D.G., Schwartz M.W. Insulin and the blood-brain barrier. Curr Pharm Des 2003, 9:795-800.
314. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001, 86:5992.
315. Wu Q., Boyle M.P., Palmiter R.D. Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation. Cell 2009, 137:1225-1234.
316. Xia Y., Wikberg J.E. Postnatal expression of melanocortin-3 receptor in rat diencephalon and mesencephalon. Neuropharmacology 1997, 36:217-224.
317. Yamamoto H., Maeda T., Fujimura M., Fujimiya M. Urocortin-like immunoreactivity in the substantia nigra, ventral tegmental area and Edinger-Westphal nucleus of rat. Neurosci Lett 1998, 243:21-24.
318. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K., Sugiyama F., Goto K., Yanagisawa M., Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003, 38:701-713.
319. Yang S.-C., Shieh K.-R., Li H.-Y. Cocaine- and amphetamine-regulated transcript in the nucleus accumbens participates in the regulation of feeding behavior in rats. Neuroscience 2005, 133:841-851.
320. Yim C.C., Mogenson G.J. Electrophysiological evidence of modulatory interaction between dopamine and cholecystokinin in the nucleus accumbens. Brain Res 1991, 541:12-20.
321. Zachariou V., Parikh K., Picciotto M.R. Centrally administered galanin blocks morphine place preference in the mouse. Brain Res 1999, 831:33-42.
322. Zahm D.S., Grosu S., Williams E.A., Qin S., Berod A. Neurons of origin of the neurotensinergic plexus enmeshing the ventral tegmental area in rat: retrograde labeling and in situ hybridization combined. Neuroscience 2001, 104:841-851.
323. Zhang M., Kelley A.E. Enhanced intake of high-fat food following striatal mu-opioid stimulation: microinjection mapping and fos expression. Neuroscience 2000, 99:267-277.
324. Zheng H., Patterson L.M., Berthoud H.R. Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. J Neurosci 2007, 27:11075-11082.
325. Zhou Q.Y., Palmiter R.D. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 1995, 83:1197-1209.
326. Zigman J.M., Jones J.E., Lee C.E., Saper C.B., Elmquist J.K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 2006, 494:528-548.
327. Zorrilla E.P., Logrip M.L., Koob G.F. Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol 2014, 35:234-244.
328. Zucker L.M., Antoniades H.N. Insulin and obesity in the Zucker genetically obese rat "fatty". Endocrinology 1972, 90:1320-1330.